{
  "trial_id": "NCT01247363",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, body mass index (BMI), fasting blood glucose (FBG), glycated hemoglobin (HbA1c) level, blood pressure (systolic and diastolic), serum creatinine, fasting serum triglycerides, history of cardiovascular events, history of hypoglycemic events, use of anti-diabetic agents, smoking status, alcohol intake, clinical laboratory test results, venous access sufficiency, history of drug or alcohol abuse, history of significant medical conditions (e.g., cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, hematological, neurological disorders).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Fasting Blood Glucose (FBG)",
          "fasting blood glucose (FBG)"
        ],
        [
          "Glycated Hemoglobin (HbA1c)",
          "glycated hemoglobin (HbA1c) level"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "blood pressure (systolic and diastolic)",
        "serum creatinine",
        "fasting serum triglycerides",
        "history of cardiovascular events",
        "history of hypoglycemic events",
        "use of anti-diabetic agents",
        "smoking status",
        "alcohol intake",
        "clinical laboratory test results",
        "venous access sufficiency",
        "history of drug or alcohol abuse",
        "history of significant medical conditions (e.g., cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, hematological, neurological disorders)"
      ]
    },
    "processed-gen-response": "Age, sex, body mass index (BMI), fasting blood glucose (FBG), glycated hemoglobin (HbA1c) level, blood pressure (systolic and diastolic), serum creatinine, fasting serum triglycerides, history of cardiovascular events, history of hypoglycemic events, use of anti-diabetic agents, smoking status, alcohol intake, clinical laboratory test results, venous access sufficiency, history of drug or alcohol abuse, history of significant medical conditions (e.g., cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, hematological, neurological disorders)."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Fasting Blood Glucose, Glycated Hemoglobin (HbA1c), Systolic Blood Pressure, Diastolic Blood Pressure, Duration of Diabetes, Use of Anti-diabetic Agents, Smoking Status, Alcohol Consumption, Serum Creatinine, Alanine Transaminase Levels, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Fasting Blood Glucose (FBG)",
          "Fasting Blood Glucose"
        ],
        [
          "Glycated Hemoglobin (HbA1c)",
          "Glycated Hemoglobin (HbA1c)"
        ]
      ],
      "remaining_reference_features": [
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Duration of Diabetes",
        "Use of Anti-diabetic Agents",
        "Smoking Status",
        "Alcohol Consumption",
        "Serum Creatinine",
        "Alanine Transaminase Levels"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Fasting Blood Glucose, Glycated Hemoglobin (HbA1c), Systolic Blood Pressure, Diastolic Blood Pressure, Duration of Diabetes, Use of Anti-diabetic Agents, Smoking Status, Alcohol Consumption, Serum Creatinine, Alanine Transaminase Levels"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Fasting Blood Glucose, HbA1c, Systolic Blood Pressure, Diastolic Blood Pressure, History of Cardiovascular Disease, History of Seizure Disorder, Family History of Long QT Syndrome, Family History of Sudden Unexplained Death.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Fasting Blood Glucose (FBG)",
          "Fasting Blood Glucose"
        ],
        [
          "Glycated Hemoglobin (HbA1c)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "History of Cardiovascular Disease",
        "History of Seizure Disorder",
        "Family History of Long QT Syndrome",
        "Family History of Sudden Unexplained Death"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Fasting Blood Glucose, HbA1c, Systolic Blood Pressure, Diastolic Blood Pressure, History of Cardiovascular Disease, History of Seizure Disorder, Family History of Long QT Syndrome, Family History of Sudden Unexplained Death."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "age, sex, race, ethnicity, body mass index (BMI), fasting blood glucose (FBG), glycated haemoglobin (HbA1c), systolic blood pressure (SBP), diastolic blood pressure (DBP), type 2 diabetes mellitus (T2DM) treatment history, duration of T2DM diagnosis.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Fasting Blood Glucose (FBG)",
          "fasting blood glucose (FBG)"
        ],
        [
          "Glycated Hemoglobin (HbA1c)",
          "glycated haemoglobin (HbA1c)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "body mass index (BMI)",
        "systolic blood pressure (SBP)",
        "diastolic blood pressure (DBP)",
        "type 2 diabetes mellitus (T2DM) treatment history",
        "duration of T2DM diagnosis."
      ]
    },
    "processed-gen-response": "age, sex, race, ethnicity, body mass index (BMI), fasting blood glucose (FBG), glycated haemoglobin (HbA1c), systolic blood pressure (SBP), diastolic blood pressure (DBP), type 2 diabetes mellitus (T2DM) treatment history, duration of T2DM diagnosis."
  }
}